Literature DB >> 8842042

Transcription regulation of rat glutathione S-transferase Ya subunit gene expression by chemopreventive agents.

P Fei1, G A Matwyshyn, T H Rushmore, A N Kong.   

Abstract

PURPOSE: To study the transcription regulation of rat glutathione S-transferase Ya (rGSTya) subunit gene expression by chemopreventive agents.
METHODS: The effects of chemopreventive agents; tamoxifen, genistein, oltipraz, indole-3-carbinol, and various isothiocyanates-sulforaphane, PMITC, PEITC, PBITC, and PPITC, on the transcriptional activation of rGSTya were investigated in cell culture. These were accomplished with a stable human hepatoma Hep G2 cell line transfected with a 1.6 kilobase (kb) 5'-flanking region of the rGSTya fused with the chloramphenicol acetyltransferase (CAT) reporter gene. Concentration-effect relationship and the kinetics of gene activation following treatments of the cells with different chemopreventive agents were carried out by quantitating CAT reporter protein using ELISA. Northern blot analysis of total RNA on the expression of CAT mRNA as well as potential transcription factors such as c-Jun, c-Fos, and LFR-1 were performed.
RESULTS: Treatment of the cells with increasing concentrations of different chemopreventive agents resulted in corresponding increases in the gene expression of CAT reporter protein. Kinetically, induction of CAT protein was seen as early as 3 hr and peaked at about 20 hr. Northern blot analysis revealed an increase in CAT mRNA transcripts and these mRNA inductions in general were in agreement with those quantitated by the production of CAT reporter protein. Induction of the transcription factor, c-Jun mRNA was observed with sulforaphane.
CONCLUSIONS: These results show that different chemopreventive agents transcriptionally activate rGSTya CAT in a time and dose-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842042     DOI: 10.1023/a:1016006707613

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Differential expression of the phenol family of UDP-glucuronosyltransferases in hepatoma cell lines.

Authors:  A N Kong; P Fei; B K Wong
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

2.  Genistein, a specific inhibitor of tyrosine-specific protein kinases.

Authors:  T Akiyama; J Ishida; S Nakagawa; H Ogawara; S Watanabe; N Itoh; M Shibuya; Y Fukami
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

3.  Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.

Authors:  R C Moon; G J Kelloff; C J Detrisac; V E Steele; C F Thomas; C C Sigman
Journal:  Anticancer Res       Date:  1994 Jan-Feb       Impact factor: 2.480

4.  Two adjacent AP-1-like binding sites form the electrophile-responsive element of the murine glutathione S-transferase Ya subunit gene.

Authors:  R S Friling; S Bergelson; V Daniel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

5.  Genistein but not staurosporine can inhibit the mitogenic signal evoked by lithium in rat thyroid cells (FRTL-5).

Authors:  T Takano; K Takada; H Tada; S Nishiyama; N Amino
Journal:  J Endocrinol       Date:  1994-11       Impact factor: 4.286

6.  Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.

Authors:  T Primiano; P A Egner; T R Sutter; G J Kelloff; B D Roebuck; T W Kensler
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

7.  Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo.

Authors:  D M Stresser; D E Williams; L I McLellan; T M Harris; G S Bailey
Journal:  Drug Metab Dispos       Date:  1994 May-Jun       Impact factor: 3.922

8.  Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype.

Authors:  M E Bracke; C Charlier; E A Bruyneel; C Labit; M M Mareel; V Castronovo
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

9.  Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.

Authors:  M A Anzano; S W Byers; J M Smith; C W Peer; L T Mullen; C C Brown; A B Roberts; M B Sporn
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

10.  Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.

Authors:  T M Buetler; E P Gallagher; C Wang; D L Stahl; J D Hayes; D L Eaton
Journal:  Toxicol Appl Pharmacol       Date:  1995-11       Impact factor: 4.219

View more
  3 in total

Review 1.  Pharmacodynamics and toxicodynamics of drug action: signaling in cell survival and cell death.

Authors:  A N Kong; S Mandlekar; R Yu; W Lei; A Fasanmande
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  Activation of signal transduction kinases by tamoxifen.

Authors:  J L Duh; R Yu; J J Jiao; G A Matwyshyn; W Li; T H Tan; A N Kong
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

3.  Differential induction of mafF, mafG and mafK expression by electrophile-response-element activators.

Authors:  Julie A Moran; Erica L Dahl; R Timothy Mulcahy
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.